Summa Biotech

Over Summa Biotech

Summa Biotech is a medical biotech company that is founded in 2022 and focuses on developing ground-breaking RNA-based medicines that reverse the damage of ischemic heart disease, which is a leading cause of death worldwide.

We aim restore damaged heart tissue by eliciting the regeneration of healthy cells and tissues using RNA therapeutics.

Summa Biotech’s strategy is to develop game-changing curative therapies for ischemic heart disease by leveraging academic expertise, cutting-edge disease models and fostering a culture of team excellence.

Trefwoorden

• Heart Failure
• Regenerative Medicine
• Rna Therapeutics

Adres

• Hoofdkantoor

  Klokkenbergweg 81101AS AmsterdamNoord-Holland, Nederland

Team per functiegebied

Gebaseerd op 9 openbare functieprofielen, stand van 3 september 2026.

• Research / R&D3
• Executive / C-Suite2
• Founder / Owner2
• Other / Unclassifiable2